483 Concord Biomedical Science and Emerging Technologies May 2019

483 Concord Biomedical Science and Emerging Technologies May 2019

Kent Conforti FDA$119.00 - Available Now

FDA investigators audited the Concord Biomedical Science and Emerging Technologies - Lexington, MA, United States facility and issued inspectional observations (via FDA 483) on 23 May 2019.

Product details

  • Category: Medical Devices & Rad Health
  • Inspection end: 23 May 2019
  • Location: Lexington, United States
  • FEI: 3006089773
Add To Cart